Thursday, September 10, 2015

How to Administer Intravenous Laetrile

How to Administer Intravenous Laetrile

Laetrile, also known as amygdalin, sarcarcinase or vitamin B17, is a type of nitriloside believed by some researchers to slow the metastasis of, or even cure, cancer. Nitrilosides are naturally occurring "cyanide-containing" substances found in the pits of many fruits, such as the apricot family. The compound was synthesized in 1924 and became the subject of experimental cancer treatments that included vitamin and nutritional supplementation in the 1960s and 1970s. Laetrile can be administered by mouth or intravenously by a method known as "slow IV push."

Instructions

The Gupta Protocol for Laetrile Administration

    1
    Disinfect the vial top.
    Disinfect the vial top.

    Flip off the plastic top on the Laetrile vial that protects the rubber membrane. Tear open an alcohol prep pad envelope and use the pad to disinfect the rubber top of the 10cc vial.

    2
    Fill by syringe more easily by first displacing the solution with air.
    Fill by syringe more easily by first displacing the solution with air.

    Hold the 20cc syringe in your dominant hand. Remove the needle cap and pull back on the syringe plunger to the 20cc hash mark on the syringe column. Hold the vial upside down in one hand and the uncapped syringe in your dominant hand. Being careful not to touch the top of the now-disinfected vial, puncture the top of the rubber membrane and push the plunger completely to add 20cc of air to the sealed vial. You can now easily withdrawal 20cc of the laetrile solution by pulling back on the syringe plunger until the 20cc hash mark is reached. Put the empty vial aside and carefully replace the needle cover on the syringe lightly.

    3
    Disinfect the skin around the vein you plan to use for laetrile administration.
    Disinfect the skin around the vein you plan to use for laetrile administration.

    Put on a pair of gloves. Apply the rubber tourniquet above the patient's elbow by wrapping it once tightly around the arm, crossing the ends into a simple twist and tucking one end as a "U" under the rubber banding. Hold the patient's arm in a dependent position and tap lightly on the inside arm, from elbow to wrist, to find a vein. When located, disinfect the planned site with another alcohol prep pad.

    4
    Ensure that there are no air bubbles in the syringe.
    Ensure that there are no air bubbles in the syringe.

    Remove the syringe needle cover and hold the syringe needle up. Tap lightly on the syringe to move any air bubbles to the top. Slowly push on the plunger until a drop of the laetrile solution beads at the needle tip.

    5
    Insert the needle into the vein.
    Insert the needle into the vein.

    Insert the syringe needle in a forward, but slightly downward angle, until the vein is punctured. Pull on the end of the tourniquet closest to the "U" to release the band. Slowly begin to depress the plunger so the medication is given over a one- to two-minute period. Hold the syringe and the patient's arm or hand steady to avoid the needle slipping out of the vein or puncturing the other side.

    6
    Dispose of all used needles in a biohazard container.
    Dispose of all used needles in a biohazard container.

    Remove the needle from the vein when the solution is administered. Hold pressure over the site with a cotton ball to allow the blood to clot. Dispose of the used syringe by placing it directly into the biohazard container. Do not attempt to replace the syringe cover before disposal. Apply a Band-Aid to the site after the bleeding has stopped from the administration site.

The Gupta Protocol Schedule for Laetrile Administration

    7

    Give laetrile intravenously three times per week for three weeks, allowing at least one day between treatments. For example, a Monday, Wednesday and Friday treatment schedule would be appropriate.

    8

    Give one vial of laetrile (10cc or 3 g) for the patient's first treatment.

    9

    Administer two vials of laetrile (20cc or 6 g) for the patient's second and third treatments.

    10

    Administer three vials of laetrile (30cc or 9 g) for the patient's fourth through ninth treatments.

    11

    Begin a maintenance program of one vial (10cc or 3 g) once weekly for three months.

No comments:

Post a Comment